South Korea · Delayed Price · Currency is KRW METACARE CO. Statistics
Total Valuation
METACARE CO. has a market cap or net worth of KRW 30.92 billion. The enterprise value is 89.98 billion.
| Market Cap | 30.92B |
| Enterprise Value | 89.98B |
Important Dates
The next estimated earnings date is Friday, May 22, 2026.
| Earnings Date | May 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
METACARE CO. has 17.18 million shares outstanding. The number of shares has increased by 13.04% in one year.
| Current Share Class | 17.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +13.04% |
| Shares Change (QoQ) | -0.42% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 9.92M |
Valuation Ratios
The trailing PE ratio is 60.87.
| PE Ratio | 60.87 |
| Forward PE | n/a |
| PS Ratio | 0.94 |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 12.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.44, with an EV/FCF ratio of -3.95.
| EV / Earnings | 180.60 |
| EV / Sales | 2.74 |
| EV / EBITDA | 19.44 |
| EV / EBIT | 67.92 |
| EV / FCF | -3.95 |
Financial Position
The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.49.
| Current Ratio | 0.34 |
| Quick Ratio | 0.28 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 12.82 |
| Debt / FCF | -2.60 |
| Interest Coverage | 0.54 |
Financial Efficiency
Return on equity (ROE) is -0.18% and return on invested capital (ROIC) is 0.74%.
| Return on Equity (ROE) | -0.18% |
| Return on Assets (ROA) | 0.47% |
| Return on Invested Capital (ROIC) | 0.74% |
| Return on Capital Employed (ROCE) | 0.90% |
| Weighted Average Cost of Capital (WACC) | 4.97% |
| Revenue Per Employee | 1.06B |
| Profits Per Employee | 16.07M |
| Employee Count | n/a |
| Asset Turnover | 0.18 |
| Inventory Turnover | 22.91 |
Taxes
In the past 12 months, METACARE CO. has paid 7.04 million in taxes.
| Income Tax | 7.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.79% in the last 52 weeks. The beta is 0.73, so METACARE CO.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -42.79% |
| 50-Day Moving Average | 2,534.88 |
| 200-Day Moving Average | 3,003.37 |
| Relative Strength Index (RSI) | 21.34 |
| Average Volume (20 Days) | 147,949 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, METACARE CO. had revenue of KRW 32.82 billion and earned 498.24 million in profits. Earnings per share was 29.57.
| Revenue | 32.82B |
| Gross Profit | 9.97B |
| Operating Income | 1.32B |
| Pretax Income | -204.92M |
| Net Income | 498.24M |
| EBITDA | 4.63B |
| EBIT | 1.32B |
| Earnings Per Share (EPS) | 29.57 |
Balance Sheet
The company has 1.82 billion in cash and 59.32 billion in debt, with a net cash position of -57.50 billion or -3,347.56 per share.
| Cash & Cash Equivalents | 1.82B |
| Total Debt | 59.32B |
| Net Cash | -57.50B |
| Net Cash Per Share | -3,347.56 |
| Equity (Book Value) | 120.98B |
| Book Value Per Share | 6,952.18 |
| Working Capital | -34.03B |
Cash Flow
In the last 12 months, operating cash flow was 2.42 billion and capital expenditures -25.21 billion, giving a free cash flow of -22.79 billion.
| Operating Cash Flow | 2.42B |
| Capital Expenditures | -25.21B |
| Depreciation & Amortization | 3.30B |
| Net Borrowing | 25.64B |
| Free Cash Flow | -22.79B |
| FCF Per Share | -1,326.66 |
Margins
Gross margin is 30.37%, with operating and profit margins of 4.04% and 1.52%.
| Gross Margin | 30.37% |
| Operating Margin | 4.04% |
| Pretax Margin | -0.62% |
| Profit Margin | 1.52% |
| EBITDA Margin | 14.10% |
| EBIT Margin | 4.04% |
| FCF Margin | n/a |
Dividends & Yields
METACARE CO. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.04% |
| Shareholder Yield | -13.04% |
| Earnings Yield | 1.61% |
| FCF Yield | -73.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 24, 2026. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
METACARE CO. has an Altman Z-Score of -0.1 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.1 |
| Piotroski F-Score | 6 |